Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)

Balazs Halmos, Eng Huat Tan, Ross A. Soo, Jacques Cadranel, Min Ki Lee, Pascal Foucher, Te Chun Hsia, Maximilian Hochmair, Frank Griesinger, Toyoaki Hida, Edward Kim, Barbara Melosky, Angela Märten, Enric Carcereny

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases